Trillium Therapeutics Inc. Gains 43.66%

Wed 09 Sep 20 at 05:30 PM
Trillium Therapeutics Inc. Gains 43.66%

Trillium Therapeutics Inc. (TRIL:NASDAQ) rocketted at $13.59, representing a gain of 43.7%. On Tue 08 Sep 20, TRIL:NASDAQ hit a New 2-Week Low of $9.46. The stock got featured on our News Catalysts scanner on Wed 09 Sep 20 at 04:09 PM in the 'PUBLIC OFFERING' category. From Tue 25 Aug 20, the stock recorded 33.33% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.